The expression of the chemokine receptor CXCR3 and its ligand, CXCL10, in human breast adenocarcinoma cell lines
- 29 March 2004
- journal article
- Published by Elsevier BV in Immunology Letters
- Vol. 92 (1-2), 171-178
- https://doi.org/10.1016/j.imlet.2003.10.020
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Progression of mouse mammary tumors: MCP‐1‐TNFα cross‐regulatory pathway and clonal expression of promalignancy and antimalignancy factorsInternational Journal of Cancer, 2003
- IL-8 expression and its possible relationship with estrogen-receptor-negative status of breast cancer cellsOncogene, 2003
- Circulating interleukin‐6 predicts survival in patients with metastatic breast cancerInternational Journal of Cancer, 2002
- A Potential Role for Interleukin-8 in the Metastatic Phenotype of Breast Carcinoma CellsThe American Journal of Pathology, 2001
- Combined CXC chemokine and interleukin-12 gene transfer enhances antitumor immunityGene Therapy, 2001
- The chemokine receptor CXCR3 is expressed on malignant B cells and mediates chemotaxisJCI Insight, 1999
- Molecular mechanisms of G protein-coupled receptor desensitization and resensitizationLife Sciences, 1998
- Angiogenesis and inflammation in invasive carcinoma of the breast.Journal of Clinical Pathology, 1997
- Interferon γ-Inducible Protein-10 (IP-10), a Member of the C-X-C Chemokine Family, Is an Inhibitor of AngiogenesisBiochemical and Biophysical Research Communications, 1995
- Tumour‐associated leucocytes: Friends or foes in breast carcinomaThe Journal of Pathology, 1994